Owens & Minor (NYSE:OMI) was downgraded by Zacks Investment Research from a “hold” rating to a “strong sell” rating in a research note issued on Friday.

According to Zacks, “Owens & Minor, Inc. is a global healthcare solutions company dedicated to Connecting the World of Medical Products to the Point of CareSM by providing vital supply chain services to healthcare providers and manufacturers of healthcare products. Owens & Minor provides logistics services across the spectrum of medical products from disposable medical supplies to devices and implants. With logistics platforms strategically located in the United States and Europe, Owens & Minor serves markets where three quarters of global healthcare spending occurs. Owens & Minor’s customers span the healthcare market from independent hospitals to large integrated healthcare networks, as well as group purchasing organizations, healthcare products manufacturers, the federal government, and healthcare patients at home through the Byram Healthcare subsidiary. “

OMI has been the subject of several other research reports. J P Morgan Chase & Co reissued an “underweight” rating and set a $22.00 price objective on shares of Owens & Minor in a research note on Tuesday, December 19th. Credit Suisse Group reissued an “underperform” rating and set a $17.00 price objective (down previously from $31.00) on shares of Owens & Minor in a research note on Monday, November 20th. Robert W. Baird reissued a “hold” rating and set a $28.00 price objective on shares of Owens & Minor in a research note on Thursday, October 12th. Finally, Leerink Swann reissued a “market perform” rating and set a $23.00 price objective (down previously from $34.00) on shares of Owens & Minor in a research note on Thursday, November 2nd. Five research analysts have rated the stock with a sell rating and three have issued a hold rating to the company. Owens & Minor has a consensus rating of “Sell” and a consensus target price of $26.50.

Owens & Minor (NYSE OMI) opened at $18.92 on Friday. The firm has a market capitalization of $1,186.41, a price-to-earnings ratio of 14.78, a PEG ratio of 2.09 and a beta of 0.87. Owens & Minor has a 52-week low of $17.75 and a 52-week high of $37.02. The company has a debt-to-equity ratio of 0.91, a current ratio of 1.77 and a quick ratio of 0.95.

Owens & Minor (NYSE:OMI) last posted its quarterly earnings data on Wednesday, November 1st. The company reported $0.40 earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of $0.50 by ($0.10). The business had revenue of $2.33 billion for the quarter, compared to the consensus estimate of $2.40 billion. Owens & Minor had a net margin of 0.83% and a return on equity of 10.85%. Owens & Minor’s quarterly revenue was down 3.4% on a year-over-year basis. During the same period in the prior year, the business posted $0.51 EPS. analysts anticipate that Owens & Minor will post 1.77 EPS for the current year.

A number of large investors have recently bought and sold shares of OMI. Flinton Capital Management LLC lifted its stake in Owens & Minor by 62.7% during the second quarter. Flinton Capital Management LLC now owns 3,904 shares of the company’s stock worth $126,000 after purchasing an additional 1,504 shares during the last quarter. Legg Mason Asset Management Japan Co. Ltd. bought a new stake in Owens & Minor during the second quarter worth about $171,000. Riverhead Capital Management LLC lifted its stake in Owens & Minor by 65.6% during the second quarter. Riverhead Capital Management LLC now owns 6,128 shares of the company’s stock worth $197,000 after purchasing an additional 2,428 shares during the last quarter. Oppenheimer & Co. Inc. lifted its stake in Owens & Minor by 42.9% during the third quarter. Oppenheimer & Co. Inc. now owns 9,376 shares of the company’s stock worth $274,000 after purchasing an additional 2,816 shares during the last quarter. Finally, QS Investors LLC lifted its stake in Owens & Minor by 22.7% during the second quarter. QS Investors LLC now owns 9,737 shares of the company’s stock worth $313,000 after purchasing an additional 1,803 shares during the last quarter. 97.68% of the stock is owned by institutional investors.

TRADEMARK VIOLATION NOTICE: “Owens & Minor (OMI) Stock Rating Lowered by Zacks Investment Research” was posted by TheOlympiaReport and is the property of of TheOlympiaReport. If you are reading this report on another site, it was stolen and republished in violation of international trademark and copyright legislation. The legal version of this report can be read at https://theolympiareport.com/2017/12/24/owens-minor-omi-stock-rating-lowered-by-zacks-investment-research.html.

Owens & Minor Company Profile

Owens & Minor, Inc is a healthcare services company that connects the world of medical products to the point of care. The Company provides supply chain assistance to the providers of healthcare services and the manufacturers of healthcare products, supplies and devices. The Company’s segments include Domestic, International and Clinical & Procedural Solutions (CPS).

Analyst Recommendations for Owens & Minor (NYSE:OMI)

Receive News & Ratings for Owens & Minor Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Owens & Minor and related companies with MarketBeat.com's FREE daily email newsletter.